[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650704":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":36,"locations":26,"responsibleParty":41,"collaborators":43,"id":47,"slug":48,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":23,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":26,"enrollmentInfo":55,"targetDuration":26,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":66,"whyStopped":26,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":26},{"fullName":5,"class":6},"Johns Hopkins Bloomberg School of Public Health","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of Care (Control)","ACTIVE_COMPARATOR","Standard of Care (Control Arm): Participants randomized to the control arm will continue to receive standard HIV and substance use care available through the participant's usual healthcare providers. In addition, participants will receive a one-time consultation with a social worker (in person or remotely) and complete study assessments at baseline, 3 months, and 6 months. No stigma-reduction intervention sessions will be provided.",[13],"Behavioral: standard of care",{"label":15,"type":16,"description":17,"interventionNames":18},"Intervention Arm","EXPERIMENTAL","Experimental Intervention Arm: Participants randomized to the intervention arm will continue to receive standard HIV and substance use care, a one-time consultation with a social worker, and complete study assessments at baseline, 3 months, and 6 months. In addition, they will participate in five in-person, small-group sessions delivered over approximately 2-3 weeks that focus on reducing HIV- and drug use-related stigma through cognitive-behavioral coping skills, communication and social support strategies, and HIV care engagement. Participants may also complete an optional individual session with a psychologist facilitator and a support person.",[19],"Behavioral: Light Inside",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"BEHAVIORAL","Light Inside","Adapted intersectional stigma reduction intervention consisting of five facilitator-led, small-group sessions delivered over approximately 2-3 weeks. The intervention uses cognitive-behavioral strategies to reduce HIV- and drug use-related stigma by strengthening adaptive coping, cognitive restructuring, communication skills, social support, and HIV care self-efficacy to improve HIV care engagement and antiretroviral therapy adherence. Participants may also complete an optional individual session with a psychologist facilitator and a support person.",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"standard of care","Standard of Care: Participants will continue to receive standard HIV and substance use care available through their usual healthcare providers. In addition, they will receive a one-time consultation with a social worker, delivered either in person or remotely, to provide support and linkage to available services.",[9],[32],{"name":33,"affiliation":34,"role":35},"Jill Owczarzak, PhD","Johns Hopkins University","PRINCIPAL_INVESTIGATOR",[37],{"name":33,"role":38,"phone":39,"phoneExt":26,"email":40},"CONTACT","667-306-8360","jillowczarzak@jhu.edu",{"type":42,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR",[44],{"name":45,"class":46},"Fogarty International Center of the National Institute of Health","NIH","100650704","adaptation-and-evaluation-of-an-intersectional-stigma-reduction-intervention-to-increase-hiv-care-engagement-among-women-who-use-drugs-100650704",false,"NCT07751978","Adaptation and Evaluation of an Intersectional Stigma Reduction Intervention to Increase HIV Care Engagement Among Women Who Use Drugs","Inclusion Criteria:\n\n* Female; Age 18 years or older;\n* Registered in the national Medical Information System (MIS) as having received an HIV-positive diagnosis;\n* Registered in the MIS with injection drug use (IDU) as the probable mode of HIV transmission or with a documented history of injection drug use at any clinical visit.\n\nExclusion Criteria:\n\n* Does not meet the inclusion criteria;\n* Unable to provide informed consent;\n* Unable to provide informed consent due to intoxication, the effects of drug use, or severe psychiatric impairment at the time of consent.","FEMALE","18 Years",{"count":56,"type":57},100,"ESTIMATED","INTERVENTIONAL",[60],"NA","The goal of this study is to test whether a program reduce stigma will help women living HIV remain in HIV care.",[63],"HIV",[65],"HIV, women who use drugs, HIV care engagement, cognitive behavioral interventions","NOT_YET_RECRUITING","2026-08-04",{"date":69,"type":70},"2026-08-07","ACTUAL",{"date":72,"type":57},"2026-10",{"date":74,"type":57},"2028-09",{"name":5,"class":6}]